A 6-Year Follow-Up Study Of the analyzed data from 70 patients with pancreatic cancer, the main independent prognostic factor for overall survival (OS) was TNM stage. The majority of patients had ...
In order to estimate the time it takes for a pancreatic cancer to progress through different tumor, node, metastasis (TNM) stages, we compared the mean age of patients with pancreatic cancers of ...
BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are uncommon and heterogeneous neoplasms, often exhibiting indolent biological behavior. Their incidence is rising, largely due to the widespread ...
Similarly, a previous study (3) analyzed pancreatic cancer samples, identifying TLS-associated marker ... E-TLS density in the IM region and TNM stage emerged as independent prognostic factors. Immune ...
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...
3don MSN
Scientists of the University Medical Center Göttingen (UMG) have identified new interactions between pancreatic cancer cells ...
The new findings show the cancer mortality rate declined by 34% from 1991 to 2022 in the United States, averting ... Experimental Blood Test for Pancreatic Cancer Undergoing Clinical Development ...
An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients. An experimental blood test for ...
Pancreatic cancer, one of the most formidable, could soon see its treatment transformed. Researchers have identified an enzyme, Mical2, which plays a central role in the progression of this disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback